Pemetinib/pemetinib domestic price 2025 latest price per bottle
Pemigatinib is a fibroblast growth factor receptor (FGFR)-targeted drug that is mainly used to treat advanced cholangiocarcinoma (CCA) carrying FGFR2 gene rearrangements. By inhibiting the activity of FGFR, this drug can effectively reduce the proliferation of tumor cells, thus delaying the progression of the disease. Pemetinib has shown promising efficacy in clinical trials, especially for patients who have failed to respond to traditional chemotherapy or other targeted therapies, providing a new treatment option.
In the domestic market, pemetinib is marketed in the form of pemetinib tablets. There are currently two specifications available: 4.5mg 14 tablets and 9mg 14 tablets. However, the drug is not yet covered by national health insurance, which results in its relatively high price. According to market information, the selling price of pemetinib is usually between RMB 20,000 and RMB 50,000 per box. The specific price may vary depending on regions, pharmacies and other factors. This high price places a certain financial burden on many patients, especially when long-term medication is required.
In addition to the original drug, generic versions of pemetinib also exist in overseas markets. These generic drugs are similar in ingredients and effects to the original drugs and are designed to provide patients with a more economical choice. For example, the 4.5mg*14-tablet generic drug produced by Lucius Pharmaceuticals in Laos sells for about more than 700 yuan per box, which is much cheaper than the original drug. This is a good choice for some patients who want to reduce their medication costs. However, when purchasing generic drugs, patients still need to pay attention to the source and quality of the drugs to ensure that they meet relevant drug safety standards.
Overall, pemetinib, as a new targeted drug, has shown important value in the treatment of biliary tract cancers carryingFGFR2 gene rearrangements.
Reference materials:https://go.drugbank.com/drugs/DB15102
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)